Showing results (1551-1560 of 3,551) with videos related to

Sort By:
Pageof 356
Thoracic Cancer|March 16, 2023
MARVELD3 inhibits the epithelial-mesenchymal transition and cell migration by suppressing the Wnt/β-catenin signaling pathway in non-small cell lung cancer cellsShirong Li, Saiping Qi, Yanmeng Li, et al.
Thoracic Cancer|March 20, 2023
Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case reportShuntaro Hiro, Shuhei Teranishi, Tomoe Sawazumi, et al.
Thoracic Cancer|March 21, 2023
Savolitinib versus crizotinib for treating MET positive non-small cell lung cancerKang Miao, Xiaotong Zhang, Hanping Wang, et al.
Thoracic Cancer|May 5, 2021
Severe immune-related hyperthermia followed by immune-related pneumonitis with PD-1 inhibitor (sintilimab) in small cell lung cancer: A case reportYi-Hui Li, Yang Zhou, Yuan-Yuan Liu, et al.
Thoracic Cancer|May 5, 2021
Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational studyBertrand Chollet, Julien Guinde, Sophie Laroumagne, et al.
Thoracic Cancer|May 6, 2021
Calcification in thymomas can predict invasiveness to surrounding organsMitsuteru Yoshida, Kazuya Kondo, Naoki Miyamoto, et al.
Thoracic Cancer|May 6, 2021
Ultrathin bronchoscope combined with virtual bronchoscopic navigation and endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions with or without fluoroscopy: A randomized trialXiaoxuan Zheng, Fangfang Xie, Ying Li, et al.
Thoracic Cancer|May 7, 2021
Primary ciliated muconodular papillary tumor: A rare pulmonary disease and literature review of 65 casesYanye Wang, Dan Wang, Jun Wang, et al.
Thoracic Cancer|May 3, 2021
ALK-positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long-term survival of more than seven years with sequential treatment of five ALK-inhibitors: A case reportKeisuke Yamamoto, Gouji Toyokawa, Yuka Kozuma, et al.
Thoracic Cancer|May 3, 2021
Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cellsKakeru Hisakane, Masahiro Seike, Teppei Sugano, et al.
Pageof 356